- Forums
- ASX - By Stock
- CSL
- Ann: Half Year Results Analyst Presentation
Ann: Half Year Results Analyst Presentation, page-132
-
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$306.92 |
Change
0.320(0.10%) |
Mkt cap ! $148.3B |
Open | High | Low | Value | Volume |
$308.93 | $311.00 | $306.28 | $94.05M | 304.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 62 | $306.91 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$306.98 | 54 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25 | 306.750 |
2 | 11 | 306.740 |
3 | 55 | 306.730 |
2 | 61 | 306.720 |
16 | 297 | 306.710 |
Price($) | Vol. | No. |
---|---|---|
306.840 | 21 | 2 |
306.870 | 14 | 2 |
306.880 | 6 | 1 |
306.920 | 5 | 1 |
306.930 | 5 | 1 |
Last trade - 13.54pm 15/07/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online